Active	Status	Sponsor type	Region	Phase	Filter
4 Active 9 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nowak, Richard M
NCT02093624: A Phase II Trial of Rituximab In Myasthenia Gravis	Not yet recruiting	2	50	US	Rituximab, Placebo	Yale University	Myasthenia Gravis	05/17	12/17
ADAPT-teleMG, NCT05917184: The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis	Completed	N/A	52	US	Telehealth	Yale University, National Institute of Neurological Disorders and Stroke (NINDS), National Center for Advancing Translational Sciences (NCATS)	Myasthenia Gravis	01/23	01/23
NCT03792659: The EXPLORE MG Registry for Myasthenia Gravis	Recruiting	N/A	800	US	Blood Sample Draw	Yale University	Myasthenia Gravis	09/26	10/26
EXPLORE-MG2, NCT06002945: Exploring Outcomes and Characteristics of Myasthenia Gravis 2	Active, not recruiting	N/A	400	US	Blood sample	Yale University, National Center for Advancing Translational Sciences (NCATS), National Institute of Neurological Disorders and Stroke (NINDS)	Myasthenia Gravis	12/26	12/26